These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23041602)

  • 21. Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.
    Hartwig UF; Nonn M; Khan S; Link I; Huber C; Herr W
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):99-109. PubMed ID: 18158966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yu WJ; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):912-920. PubMed ID: 30485788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation.
    Filatenkov A; Müller AM; Tseng WW; Dejbakhsh-Jones S; Winer D; Luong R; Shizuru JA; Engleman EG; Strober S
    J Immunol; 2009 Dec; 183(11):7196-203. PubMed ID: 19890041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer of allogeneic antigen-specific T cells.
    Riddell SR; Bleakley M; Nishida T; Berger C; Warren EH
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):9-12. PubMed ID: 16399578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination.
    Mullen CA; Campbell A; Tkachenko O; Jansson J; Hsu YC
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):226-38. PubMed ID: 20831897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.
    Riddell SR; Berger C; Murata M; Randolph S; Warren EH
    Blood Rev; 2003 Sep; 17(3):153-62. PubMed ID: 12818225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Graft-versus-leukemia as an allogeneic immune reaction].
    Shiobara S
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1351-5. PubMed ID: 16097591
    [No Abstract]   [Full Text] [Related]  

  • 28. Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect.
    Orti G; Barba P; Fox L; Salamero O; Bosch F; Valcarcel D
    Exp Hematol; 2017 Apr; 48():1-11. PubMed ID: 28027963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibility of selective induction of a GVL effect without increasing GVHD].
    Akatsuka Y
    Rinsho Ketsueki; 2008 Aug; 49(8):607-15. PubMed ID: 18800609
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccines in leukemia.
    Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
    Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
    [No Abstract]   [Full Text] [Related]  

  • 33. Graft-versus-leukemia reactions in allogeneic chimeras.
    Kolb HJ; Schmid C; Barrett AJ; Schendel DJ
    Blood; 2004 Feb; 103(3):767-76. PubMed ID: 12958064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.
    Hirosawa T; Torikai H; Yanagisawa M; Kamei M; Imahashi N; Demachi-Okamura A; Tanimoto M; Shiraishi K; Ito M; Miyamura K; Shibata K; Kikkawa F; Morishima Y; Takahashi T; Emi N; Kuzushima K; Akatsuka Y
    Cancer Sci; 2011 Jul; 102(7):1281-6. PubMed ID: 21466613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation.
    Stamouli M; Gkirkas K; Tsirigotis P
    Immunotherapy; 2016; 8(1):57-68. PubMed ID: 26641929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha interferon augments the graft-versus-leukaemia effect of second stem cell transplants and donor lymphocyte infusions in high-risk paediatric leukaemias.
    Cooper N; Rao K; Goulden N; Amrolia P; Veys P
    Br J Haematol; 2012 Feb; 156(4):550-2. PubMed ID: 21981646
    [No Abstract]   [Full Text] [Related]  

  • 38. Peptide vaccines for patients with acute myeloid leukemia.
    Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
    Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
    Warren EH; Fujii N; Akatsuka Y; Chaney CN; Mito JK; Loeb KR; Gooley TA; Brown ML; Koo KK; Rosinski KV; Ogawa S; Matsubara A; Appelbaum FR; Riddell SR
    Blood; 2010 May; 115(19):3869-78. PubMed ID: 20071660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.
    Yang YG; Qi J; Wang MG; Sykes M
    Blood; 2002 Jun; 99(11):4207-15. PubMed ID: 12010827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.